Skip to main content

Zevra Therapeutics, Inc 10-K for FY2024

Zevra Therapeutics, Inc. (ZVRA)

10-K 2025-03-12 For: 2024-12-31
View Original
Added on April 10, 2026

About this 10-K

Zevra Therapeutics, Inc filed this 10-K on March 12, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$23.61M
down 14.0% from $27.46M a year earlier
Net loss
$105.51M
compared with a net loss of $46.05M a year earlier